Deadline: February 20, 2029$11.0M

HEAL Initiative: Non-addictive Analgesic Therapeutics Development [Small Molecules and Biologics] to Treat Pain (UG3/UH3 Clinical Trial Optional)

The purpose of this Notice of Funding Opportunity (NOFO) is to support the preclinical optimization and development of safe, effective, and non-addictive small molecule and biologic therapeutics for the treatment of pain. Offered by National Institutes of Health; awards $11.0M; applications due February 20, 2029.

Key Facts

Funder
National Institutes of Health
Award amount
$11.0M
Deadline
February 20, 2029
Geography
United States
Categories
Research
Status
Open

About This Grant

The purpose of this Notice of Funding Opportunity (NOFO) is to support the preclinical optimization and development of safe, effective, and non-addictive small molecule and biologic therapeutics for the treatment of pain. The goal of the program is to accelerate the advancement of promising early-stage therapeutic candidates and facilitate their readiness for Phase II clinical trials. Applicants must have a promising small molecule or biologic lead candidate for optimization, a strong...

Full requirements and application instructions: official listing.

Similar Open Grants

Deadlines Move. Your Search Shouldn't Start Over.

Get matched to open grants by eligibility and track every deadline in one workspace.